Biogen Inc (BIIB)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	6,788,200	—	—	—	6,567,300	—	—	—	7,567,300	—	—	—	7,500,000	—	—	—	6,000,000	—	—	—
Total assets	US$ in thousands	26,844,800	28,193,200	25,156,800	24,598,400	24,554,100	24,854,200	25,081,400	23,614,400	23,877,300	23,806,700	24,470,400	23,854,700	24,618,900	24,934,100	25,511,800	26,119,200	27,234,300	27,484,000	26,287,600	26,445,500
Debt-to-assets ratio		0.25	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.30	0.00	0.00	0.00	0.22	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $6,788,200K ÷ $26,844,800K
= 0.25

The debt-to-assets ratio for Biogen Inc has been relatively stable over the past eight quarters, ranging between 0.25 and 0.31. This ratio indicates the proportion of the company's assets financed through debt, with a lower ratio typically suggesting lower financial risk. Biogen's debt-to-assets ratio has remained relatively consistent around 0.26, indicating that approximately 26% of the company's assets are financed by debt on average. The slight increase in the ratio in Q1 2022 and Q2 2022 to 0.31 and 0.29 respectively suggests a temporary increase in debt relative to assets during that period. Overall, the consistent and moderate debt-to-assets ratio for Biogen Inc signals a balanced approach to leveraging debt as a source of financing.